AzTrials
AzTrials

Intracanal MedicationEarly Phase 1NCT05687760

Effect of Bromelain Versus Calcium Hydroxide as an Intracanal Medication on the Intensity of Postoperative Pain and Bacterial Load Reduction in Necrotic Single Rooted Lower Premolars

A Early Phase 1 study testing bromelain and Calcium hydroxide in people with Intracanal Medication and Bromelain, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

the aim of the study is to compare the effect of bromelain vs calcium hydroxide as intracanal medication on intensity of pain and bacterial load in necrotic single lower premolars Read more about this study

Who is it for?
Ages 25 to 50 yearsHealthy volunteers can take part
What is being tested?
bromelain and Calcium hydroxide
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
No sites listed yet
Study dates
10 Feb 2023to 10 Feb 2023
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients who are free from any physical or mental handicapping condition with no underlying systemic disease (ASA I or II) .
  • Age between 25-50 years old.
  • Males \& Females.
  • Patients who can understand pain scale and can sign the informed consent.
  • Mandibular Single rooted premolars, having single root canal:
  • Diagnosed clinically with pulp necrosis.
Show all 10Show fewer
  • Absence of spontaneous pulpal pain.
  • Positive pain on percussion denoting apical periodontitis.
  • Slight widening in the periodontal membrane space with or without periapical radiolucency radiographically.
  • Normal occlusal contact with opposing teeth

Who cannot join

  • Medically compromised patients: Pain levels and healing following treatment would be compromised as these patients have shown higher incidence of pain and lower healing rate.
  • Pregnant women: Avoid radiation exposure, anesthesia, and medication.
  • If antibiotics have been administrated by the patient during the past 12 hours preoperatively might alter their pain perception.
  • Patients reporting bruxism or clenching: Avoid further pressure on an already inflamed tooth inducing subsequent irritation and inflammation.
  • Teeth that shows association with acute periapical abscess and swelling: Need special treatment steps which could involve additional visits with incision and drainage. Also, it could influence initiation and progression of postoperative pain.
  • Greater than grade I mobility or pocket depth greater than 5mm. Need special surgical and/or periodontal therapy.
Show all 9Show fewer
  • No restorability: Hopeless tooth.
  • Immature teeth.
  • Radiographic evidence of external or internal root resorption.

About this study

Official title: Effect of Bromelain Versus Calcium Hydroxide as an Intracanal Medication on the Intensity of Postoperative Pain and Bacterial Load Reduction in Necrotic Single Rooted Lower Premolars (A Randomized Clinical Trial)

the aim of the study is to compare the effect of bromelain vs calcium hydroxide as intracanal medication on intensity of pain and bacterial load in necrotic single lower premolars

Read the detailed description

After diagnosing the case as pulp necrosis and confirming that the patient conforms to all eligibility criteria, the operator will enroll the patient in the study.

Treatment of all cases will be completed in two visits as follows :

  1. Anesthetizing the tooth using mental nerve block technique by local anesthesia of 1.8 ml of 2% Mepivacaine HCl with 1:100,000 epinephrine (Artinibsa®; Inibsa Dental, Lliçà de Vall,Spain) .
  2. Removal of Caries and/or coronal restorations completely with sterile bur and rubber dam will be applied.
  3. Cleaning the operative field, including the tooth, the clamp, and rubber dam sheet, with 3% hydrogen peroxide until no further bubbling of the peroxide occurred. All surfaces will then be disinfected by a sterile cotton swab with a 5.25% sodium hypochlorite solution.
  4. Preparation of access cavity using another sterile round carbide bur size 3 and Endo-z bur (Dentsply Maillefer, Ballaigues, Switzerland) .
  5. After completing the access, the operative field and the pulp chamber will be cleaned and disinfected once again in the same way mentioned above. NaOCl will be then neutralized with 5% sodium thiosulfate.
  6. The pre-instrumentation root canal sample (S0) will be taken as follows: a sterile paper point will be placed in the canal to soak up the fluid in the canal to a level approximately 1 mm short of the tooth apex based on diagnostic radiographs and estimated working length. The paper point will be left in the canal for at least 1 minute. Paper points will then be transferred aseptically to tubes containing sterile brain heart infusion (BHI) broth.
  7. Confirming the patency of the root canals using stainless steel hand K-files size #10 and #15(K-Files, MANI, INC., Industrial Park, Utsunomiya, Tochigi, Japan) Working length will be determined using an electronic apex locator(Root ZX, J. Morita USA, Irvine, CA) then confirmed radiographically to be 1 mm shorter than radiographic apex.
  8. Mechanical preparation will be done using M PRO rotary files in an endodontic motor (X-Smart, Dentsply Maillefer, USA) The first file (18/.09) will be used as an orifice opener for two thirds of the working length followed by (20/.04) and (25/.06) for the full working length and finally (35/.04). In-and-out motions will be applied with stroke lengths not exceeding 3 mm in the cervical, middle, and apical thirds until attaining the established WL. The first file is used with a continuous rotary motion at a speed of 500rpm and torque of 3Ncm. The second, third and fourth files are used with a speed of 300 rpm and torque of 1.5Ncm. The canal will be irrigated and recapitulated after the use of each instrument.
  9. The canal will be thoroughly irrigated with 2.5% sodium hypochlorite root canal irrigant (5ml for 1 min) using disposable plastic syringe with side vented needle gauge 30 (Steri irrigation tips; Diadent, Chungcheongbuk-do, Korea) reaching 1 mm short of the working length. All teeth will receive the same volume of irrigant (5 ml prior to instrumentation, 5 ml between each file and 5 ml as final flush after root canal instrumentation to reach a total volume of 25 ml in total).
  10. Post-instrumentation sample (S1) will be taken as previously mentioned.
  11. The patients will then be assigned into two groups : In the intervention groups, Bromelain paste (Bromelain powder with enzymatic activity of 2400 Gelatin digestion unit per Gram was mixed with saline in 1:1 proportion 1 g powder was mixed with 1 ml distilled water) will be placed inside the canals using sterile plastic syringe with needle gauge 27 without binding 1mm shorter than working length . The access cavities were closed using sterile cotton pellet and intermediate restorative material . In the control group, Ca(OH)29will be placed inside the canals using sterile plastic syringe with needle gauge 27 without binding 1 mm shorter than working length .The access cavities were closed using sterile cotton pellet and intermediate restorative material .
  12. Patients will be asked to record their pain level after the first visit on Numeric Rating Scale (NRS) at 6, 12, 24, 48 hours.(Appendix V)
  13. Each patient will be given a chart to record postoperative swelling. If swelling was recorded, the patient will be appointed for clinical examination to assess the severity by blinded assessor in a swelling rating scale and to determine if systemic antibiotics (Augmentin 625mg/8 hours/5 days) or drainage would have been needed.
  14. In the recall appointment after 1 week. Rubber dam will be applied then intracanal medication will be removed using copious irrigation and fanta AF max rotary file (#25 0.04) and tooth will be disinfected as before. The previously sampled canal will be re-entered, flushed with copious saline irrigation and a third sample (S-2) will be taken. After the sampling, final flush with 2.5% NaOCL and 17% EDTA will be done in both groups. Master cones of (0.40) taper gutta-percha(Meta Biomed Co., Ltd, Korea) will be fitted to the working length and a radiograph will be taken to ensure proper length. Obturation will be done by modified single cone technique using epoxy resin sealer(Adseal, Meta Biomed CO.,LTD, Korea)and 4% taper gutta percha cones together with auxillary cones.
  15. The tooth will be sealed by temporary restoration ,Then the details of the endodontic procedure for each patient will be recorded in the patient's procedure chart (Appendix IV) .
  16. The patient will be instructed to return to complete the treatment procedures until placing a full-coverage restoration.
  17. In case of severe pain or persisting pain patients are instructed to take prescribed analgesic (Ibuprofen 400mg), not to take it less than 6 hours apart
Being tested
bromelain, Calcium hydroxide

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • bromelainBiological

    is a proteolytic enzyme derived from the stem part and fruit of pineapples (Ananas comosus).used as intracanal medication

  • Calcium hydroxideDrug

    calcium hydroxide

Study groups in NCT05687760
Study groupRoleWhat they receive
calcium hydroxide armActive comparatorintracanal medication of calcium hydroxide paste
Receives: Drug: Calcium hydroxide
bromelain armExperimentalintracanal medication of bromelain paste (Bromelain powder with enzymatic activity of 2400 Gelatin digestion unit per Gram was mixed with saline in 1:1 proportion 1 g powder was mixed with 1 ml distilled water)
Receives: Biological: bromelain

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. postoperative pain intensity

    measured using Numerical rating scale

    Measured: 6 hours post-instrumentation

  2. postoperative pain intensity

    measured using numerical rating scale

    Measured: 12 hours post-instrumentation

  3. postoperative pain intensity

    measured using numerical rating scale

    Measured: 24 hours post-instrumentation

  4. postoperative pain intensity

    measured using numerical rating scale

    Measured: 48 hours post-instrumentation

Secondary outcomes (7)
  1. bacterial load reduction

    using Colony forming unit (CFU )

    Measured: immediately after access preparation and pre- instrumentation.

  2. enterococcal bacterial count

    using Colony forming unit (CFU )

    Measured: immediately after access preparation and pre- instrumentation.

  3. bacterial load reduction

    using Colony forming unit (CFU )

    Measured: immediately after instrumentation

  4. enterococcal bacterial count

    using Colony forming unit (CFU )

    Measured: immediately after instrumentation

  5. bacterial load reduction

    using Colony forming unit (CFU )

    Measured: 1 week after intracanal medicament placement

  6. enterococcal bacterial count

    using Colony forming unit (CFU )

    Measured: 1 week after intracanal medicament placement

  7. Incidence of inter- appointment swelling

    using binary chart (yes or no)

    Measured: Up to 48 hours post- operatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2023
  2. Study start10 Feb 2023 (estimated)
  3. Primary completion10 Feb 2023 (estimated)
  4. Study completion10 Feb 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05687760
Sponsor's protocol ID
magy intracanal medication
Status last verified
Jan 2023
First submitted
21 Dec 2022
Last updated
18 Jan 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing bromelain and Calcium hydroxide in people with Intracanal Medication and Bromelain, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

postoperative pain intensity (time frame: 6 hours post-instrumentation). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in